Active ingredients of Incruse Ellipta 1
Incruse Ellipta 55 mcg (umeclidinium) inhalation powder.
Each single inhalation provides a delivered dose (the dose leaving the mouthpiece of the inhaler) of 55 micrograms (mcg) umeclidinium (equivalent to 65 mcg of umeclidinium bromide). This corresponds to a pre-dispensed dose of 62.5 mcg umeclidinium equivalent to 74.2 mcg umeclidinium bromide.
Incruse Ellipta Indication:
Maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). 1